Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$3.22 - $4.72 $17,066 - $25,016
-5,300 Reduced 21.2%
19,700 $67,000
Q4 2022

Feb 14, 2023

SELL
$3.03 - $3.79 $14,259 - $17,835
-4,706 Reduced 15.84%
25,000 $87,000
Q3 2022

Nov 14, 2022

SELL
$3.58 - $5.88 $46,776 - $76,828
-13,066 Reduced 30.55%
29,706 $108,000
Q2 2022

Aug 15, 2022

BUY
$5.13 - $9.2 $81,936 - $146,942
15,972 Added 59.6%
42,772 $241,000
Q1 2022

May 13, 2022

BUY
$8.64 - $11.71 $231,552 - $313,828
26,800 New
26,800 $232,000
Q4 2021

Feb 11, 2022

SELL
$10.95 - $16.07 $363,540 - $533,524
-33,200 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$12.95 - $18.24 $1,295 - $1,823
100 Added 0.3%
33,200 $430,000
Q2 2021

Aug 12, 2021

SELL
$15.83 - $17.84 $45,907 - $51,736
-2,900 Reduced 8.06%
33,100 $548,000
Q1 2021

May 17, 2021

SELL
$15.92 - $20.3 $27,064 - $34,510
-1,700 Reduced 4.51%
36,000 $618,000
Q4 2020

Feb 03, 2021

SELL
$15.65 - $19.92 $32,865 - $41,832
-2,100 Reduced 5.28%
37,700 $590,000
Q3 2020

Nov 16, 2020

BUY
$13.97 - $21.16 $134,112 - $203,136
9,600 Added 31.79%
39,800 $760,000
Q2 2020

Aug 12, 2020

BUY
$10.39 - $16.07 $9,351 - $14,463
900 Added 3.07%
30,200 $414,000
Q1 2020

May 06, 2020

BUY
$8.89 - $24.94 $37,338 - $104,748
4,200 Added 16.73%
29,300 $311,000
Q3 2019

Nov 12, 2019

BUY
$6.86 - $10.46 $172,186 - $262,546
25,100 New
25,100 $263,000
Q2 2018

Aug 03, 2018

SELL
$4.04 - $5.13 $40,400 - $51,300
-10,000 Closed
0 $0
Q3 2017

Nov 01, 2017

BUY
$4.14 - $5.12 $41,400 - $51,200
10,000
10,000 $44,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $203M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.